128 related articles for article (PubMed ID: 27237058)
1. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
[TBL] [Abstract][Full Text] [Related]
2. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
[TBL] [Abstract][Full Text] [Related]
3. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
5. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
6. Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
Wang J; Zhang KS; Wang T; Liu Z; Wang RH; Zhang FQ; Yu L; Ran L; He JL; Wang YL; Wei LC; Shi M; Wang GQ; Wu CQ; Kang QJ; Yang J; Li S; Yang FY; Liu BG; Liu JY; Shi F; Su J; Yuan W; Drokow EK
BMC Cancer; 2019 Dec; 19(1):1219. PubMed ID: 31842811
[TBL] [Abstract][Full Text] [Related]
7. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
[TBL] [Abstract][Full Text] [Related]
8. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
[TBL] [Abstract][Full Text] [Related]
9. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
10. The association of vagina equivalent dose in 2Gy fraction (EQD
Ruanla J; Muangwong P; Kittidachanan K; Tippanya D; Thongsuk W; Kongsa A; Galalae RM; Tharavichitkul E
Brachytherapy; 2022; 21(5):658-667. PubMed ID: 35715305
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
12. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
[TBL] [Abstract][Full Text] [Related]
13. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
[TBL] [Abstract][Full Text] [Related]
14. Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
Dankulchai P; Harn-Utairasmee P; Prasartseree T; Nakkasae P; Trikhirhisthit K; Sittiwong W; Thephamongkhol K; Petsuksiri J; Apiwarodom N; Iampongpaiboon P; Chansilpa Y
Radiother Oncol; 2022 Sep; 174():77-86. PubMed ID: 35839936
[TBL] [Abstract][Full Text] [Related]
15. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator.
Berger D; Dimopoulos J; Georg P; Georg D; Pötter R; Kirisits C
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1451-9. PubMed ID: 17289290
[TBL] [Abstract][Full Text] [Related]
16. Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction
Aguilera MDV; Rovirosa Á; Ascaso C; Herreros A; Sánchez J; Garcia-Migue J; Cortes S; Agusti E; Camacho C; Zhang Y; Li Y; Sabater S; Torne A; Arenas M
J Contemp Brachytherapy; 2018 Feb; 10(1):40-46. PubMed ID: 29619055
[TBL] [Abstract][Full Text] [Related]
17. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
Lee KC; Kim TH; Choi JH; Choi MS; Kim CY; Kim JY
Yonsei Med J; 2004 Feb; 45(1):113-22. PubMed ID: 15004877
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional dose accumulation in pseudo-split-field IMRT and brachytherapy for locally advanced cervical cancer.
Sun B; Yang D; Esthappan J; Garcia-Ramirez J; Price S; Mutic S; Schwarz JK; Grigsby PW; Tanderup K
Brachytherapy; 2015; 14(4):481-9. PubMed ID: 25958039
[TBL] [Abstract][Full Text] [Related]
19. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
[TBL] [Abstract][Full Text] [Related]
20. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
